Overview

A Double-blind Study of KRN321 for the Treatment of Anemia in Cancer Patients

Status:
Completed

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

To compare the effectiveness of KRN321 to placebo in the treatment of anemia in cancer patients receiving multi cycle platinum-containing chemotherapy

Phase:

Phase 3

Details

Lead Sponsor:

Kyowa Hakko Kirin Company, Limited
Kyowa Kirin Co., Ltd.

Treatments:

Darbepoetin alfa